Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines.
Balaxi Pharma's Hyderabad facility secured WHO-GMP Certification, a key milestone boosting manufacturing and quality. Production of initial products has started, enhancing its portfolio for global markets.
BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers Report of Annual General Meeting held on 24th August, 2026. Further, the company has informed the Exchange regarding Voting Results.